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Abstract
It was previously demonstrated that the methanol fraction of Sideroxylon obtusifolium (MFSOL) promoted anti-inflammatory and
healing activity in excisional wounds. Thus, the present work investigated the healing effects of MFSOL on human keratinocyte
cells (HaCaT) and experimental burn model injuries. HaCaT cells were used to study MFSOL’s effect on cell migration and
proliferation rates. Female Swiss mice were subjected to a second-degree superficial burn protocol and divided into four
treatment groups: Vehicle, 1.0% silver sulfadiazine, and 0.5 or 1.0% MFSOL Cream (CrMFSOL). Samples were collected to
quantify the inflammatory mediators, and histological analyses were performed after 3, 7, and 14 days. The results showed that
MFSOL (50 mg/mL) stimulated HaCaT cells by increasing proliferation and migration rates. Moreover, 0.5% CrMFSOL
attenuated myeloperoxidase (MPO) activity and also stimulated the release of interleukin (IL)-1b and IL-10 after 3 days of
treatment. CrMFSOL (0.5%) also enhanced wound contraction, promoted improvement of tissue remodeling, and increased
collagen production after 7 days and VEGF release after 14 days. Therefore, MFSOL stimulated human keratinocyte (HaCaT)
cells and improved wound healing via modulation of inflammatory mediators of burn injuries.
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Introduction
The reconstruction of epidermal barrier rupture through
re-epithelialization is essential to reduce wound infection
risk and to recover normal skin function (1). Burn healing
processes are affected by the interaction among cells and
molecules, including growth factors, cytokines, and chemo-
kines. Initially, the inflammatory response occurs to prevent
the invasion of pathogens and to activate fundamental
signals. It is followed by the proliferative phase, when
fibroblasts and keratinocytes restore tissue damage
through collagen synthesis, epithelialization, angiogen-
esis, and production of extracellular matrix (2,3). Infec-
tion by microorganisms causes a delay in the healing
process, increased morbidity, and worse life quality.
Thus, topical antibiotic treatment is a priority in burn
patients. In this respect, 1% silver sulfadiazine is the gold
standard (4).
The use of medicinal plants in Brazil is still common
due to both the high costs of medicines and easy access
to medicinal plants, which are widely sold in markets
throughout the country (5). Sideroxylon obtusifolium
(Roem. & Schult.) T.D. Penn is a native tree in Central
and South America. It is common in the Brazilian
semiarid region (Caatinga), where it is known as
‘‘quixaba’’ due to its round berries. It is widely used in
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folk medicine particularly in the cities of Northeast
Brazil, where the dry parts of leaves or trunk bark are
sold in local markets with claims of anti-inflammatory
and healing properties (6).
The risk of extinction of the species by the predatory
extraction of its bark has attracted attention of researchers
to other plant parts, such as the leaves. Two studies with
the hydroalcoholic fractions obtained from leaves of
S. obtusifolium showed antifungal activity against Candida
albicans (7,8). Another study demonstrated the antinoci-
ceptive and anti-inflammatory properties of an L-proline
derivative, N-methyl-(2S,4R)-trans-4-hydroxy-L-proline
(NMP), identified and isolated from the leaves of
S. obtusifolium (9). NMP is present in the decoction
from leaves of S. obtusifolium, and mainly in the methanol
soluble fraction after methanol extraction. Also, NMP shows
healing activity on excisional wounds related to its anti-
inflammatory and antioxidant actions (10). However, it is
unknown whether the proline derivative-enriched methanol
fraction (MFSOL) is involved in the healing process of
wounds caused by burns. We hypothesized that MFSOL
would promote improvement in burn healing, possibly by
stimulating migration and proliferation of keratinocytes.
These effects are essential for the healing process of
burns and other wounds that heal slowly, which present a
high risk of infection and are difficult to treat. The results
of this study demonstrated that MFSOL attenuated the
inflammatory phase and stimulated the contraction of
burns, corroborated by the in vitro stimulating migration
effect of human keratinocytes.
Material and Methods
Plant material
Leaves of S. obtusifolium (Sapotaceae) were collected
from specimens growing in the municipality of Mauriti,
state of Ceará, Brazil, in August 2014. A voucher specimen
(sample No. 10.648) was taxonomically validated by Dr.
Maria Arlene Pessoa da Silva, at the ‘‘Herbario Caririense
Dárdano de Andrade Lima’’, of Regional University of
Cariri, Ceará. The access to botanical material was
registered in the Management System of Genetic Heritage
and Associated Traditional Knowledge – SisGen, Brazil
(Registration #AE9B987). The methanol soluble fraction of
the S. obtusifolium leaf decoction (MFSOL) was obtained
according to the procedure previously described to obtain a
yellowish amorphous powder (9).
Liquid chromatography-mass spectrometry analysis
Approximately 2 mg of MFSOL was solubilized in 2 mL
of methanol. The supernatant was filtered through 0.2-mm
PTFE membranes (Whatman, Merck, Germany), and 5 mL
was injected into an Acquity UPLC (Waters Corp., USA)
chromatographic system, coupled to a quadrupole/time
of flight mass spectrometer (QTOF, Waters Corp.). The
chromatographic separation was performed with an Acquity
UPLC BEH column (150 2.1 mm, 1.7 mm; Waters Corp.)
at a temperature of 40°C. The binary gradient elution
system consisted of 0.1% formic acid in water (A) and 0.1%
formic acid in acetonitrile (B), with linear gradient from
2 to 95% B (0–15 min), with a flow rate of 0.4 mL/min.
The profiling was obtained by a Xevo Q-TOF mass
spectrometer (Waters Corp.) with electrospray ioniza-
tion (ESI) interface operating in negative ionization
mode in the range of 110–1180 Da with scan time of
0.1 s. The desolvation gas was nitrogen at 350°C
with flow rate of 500 L/h. The capillary and cone
voltages were adjusted to 3 kV and 0.5 V, respectively.
The mass accuracy and reproducibility were maintained
by infusing lockmass (leucine-enkephalin, 0.2 ng/mL;
[M-H] ion at m/z 556.2771), and molecular formula
assignments were obtained by the MassLynx 4.1 soft-
ware (Waters Corp.).
In addition, the dataset was imported to the Mass
Spectrometry – Data Independent AnaLysis software
(MS-DIAL 3.82, RIKEN Center for Integrative Medical
Sciences, Japan), to implement functions required for
untargeted metabolomics, such as obtaining deconvo-
luted spectra, peak alignment, and filtering. Therefore,
the unknown metabolites could be identified by their
elemental formulas and in silico mass spectral fragmenta-
tion with MS-FINDER 3.22 (11). Structural elucidation and
metabolite identification were performed considering the
respective m/z values and fragmentation profile (MS/MS),
with activated heuristic rules (12). Then, the compounds’
putative identification was performed by comparing the data
with information from the ChemSpider, KNApSAcK Core
System, PubChem, Human Metabolite (HMDB), and
Kyoto Encyclopedia of Genes and Genome (KEGG)
databases. Finally, chemical identification was based on
chemotaxonomy (family, genus, and species).
qHNMR analysis
The quantitative 1H nuclear magnetic resonance
(qHNMR) method was used to determine the N-methyl-
(2S,4R)-trans-4-hydroxy-L-proline (NMP) concentration
of MFSOL, where 10 g of MFSOL in 1 g aliquots was
submitted to chromatography in an SPE C18 cartridge
(20 g, Strata Phenomenex, USA) by elution with H2O
(100 mL), H2O/MeOH 3:1 (60 mL), H2O/MeOH 1:1 (60 mL),
and finally MeOH (60 mL). After lyophilization or rotary
evaporation of the solvent, the fractions yielded 3.13, 3.03,
2.03, and 1.84 g, respectively. By 1H NMR, the presence of
NMP was investigated and fractions were adsorbed
on 20 g of silica gel for flash chromatography and then
eluted with 10% CH2Cl2/MeOH (5 fractions of 50 mL),
followed by 20% CH2Cl2/MeOH (9 fractions of 50 mL and
6 fractions of 100 mL) (13).
Cell culture
Immortalized human keratinocyte cells (HaCaT, CLS
Cell Lines Service) were provided by Dr. Raquel Carvalho
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Montenegro of the Pharmacogenetics Laboratory of the
Drug Research and Development Center (NPDM), Federal
University of Ceará. Cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM, Gibcos, USA), supple-
mented with 1.0% antibiotics (100 U/mL penicillin and
100 mg/mL streptomycin, Gibcos) and 10% fetal bovine
serum (FBS, Gibcos), at 37°C in a 5% CO2 atmosphere
in a humidified incubator. The cells were maintained in
exponential growth through periodic maintenance.
Cytotoxicity assays
The principle of the MTT assay is based on the mito-
chondrial cell viability, determined by reducing, through
the succinate-tetrazole reductase enzyme system, the
yellow tetrazolium salt (MTT) to a formazan salt, which is
purple in color (14). After 24, 48, and 72 h of incuba-
tion with MFSOL, the cells received 20 mL of 3-(4,5-
dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT)
(5 mg/mL) and were incubated at 37°C for 3 h. Then, the
medium was removed and 150 mL of dimethyl sulfoxide
(DMSO) was added and the plate was homogenized for
5 min. The MFSOL was dissolved in sterile water and
used to treat the cell culture at final concentrations of
6.25–100 mg/mL. The absorbance was determined by a
microplate reader (Elisa Asys Expert Plus, UK) at a
wavelength of 540 nm.
The sulphorhodamine B (SRB) assay was used to
evaluate cell viability, based on the measurement of
cellular protein content. HaCaT cells (2 104 cells/mL)
were plated onto 96-well plates and after 24, 48, or 72 h
were treated with MFSOL (6.25–100 mg/mL). The treated
cells were fixed with 10% trichloroacetic acid and
incubated with SRB solution (0.4%) for 30 min. The
excess dye was removed by washing repeatedly with 1%
acetic acid. The protein-bound dye was dissolved in
10 mM Tris base solution and the absorbance was
determined at 570 nm using a Microplate Autoreader
(Multiskan FC, Thermo Scientific, Finland) (15). The
results are reported as a percentage of cell viability.
Scratch wound healing assay
The scratch wound healing assay was performed to
determine the effects of MFSOL on the proliferation and
migration of human keratinocytes. These cells were
dispersed in DMEM with 10% FBS (5 104 cells/mL)
and incubated with 5% CO2 at 37°C in a 24-well plate.
When the cells formed a confluent monolayer, they were
scratched using a vertical tip with 200 mL on each well.
Cell debris was removed and the wells were washed with
phosphate buffered saline (PBS). Photomicrographs
(200) were taken after 24, 48, and 72 h of incubation
with MFSOL (25, 50, and 100 mg/mL) in 1 mL of fresh
medium (16). To evaluate only the migration, an antimitotic
agent, mitomycin C (10 mg/mL; Sigmas, USA), was added
for 1 h, following the scratch protocol. Immediately there-
after, the cells were treated with MFSOL (25 and 50 mg/mL)
and, after obtaining photomicrographs, the migration
was evaluated at the initial time and after incubation for
24 and 48 h (17). The open area of the scratch was
measured using the TSCRATCHs software (ETH Zurich,
CSE Lab, Switzerland) in each analysis period at the
same initial site. The percentage of open area was
measured using the formula: Open area (%) = open area
at time X / open area at initial time  100.
Animals
Female Swiss mice (8 weeks old) were kept on a 12-h
light/dark cycle, temperature of 23±2°C, and relative
humidity of 55±10% at the Central Animal House of
Federal University of Ceará (UFC). The animals received
feed (Nuvilab, Quimtias, Brazil) and water ad libitum. The
experimental protocols were performed according to the
ethical standards established in the Ethical Principles on
Animal Experimentation adopted by Brazil’s National Council
for Control of Animal Experimentation (CONCEA), and were
approved (No. 8862290518) by the Ethics Committee on
the Use of Animals of Federal University of Ceará.
Superficial burn model and treatment
The animals were anesthetized with xylazine hydro-
chloride (10 mg/kg, ip) and ketamine hydrochloride
(100 mg/kg, ip). After anesthesia, the dorsal surface
skin (4 2 cm) was shaved followed by asepsis with
1.0% iodopovidone and then 70% ethanol. A second-
degree superficial burn was induced by direct contact
with a heated square stainless steel plate (1 cm2) at
100°C for 6 s (18). The animals were divided into
4 groups: 1) control vehicle with Lanette cream base
(anionic cream); 2) 0.5% CrMFSOL; 3) 1.0% CrMFSOL,
in which the fraction was included in the dermatological
cream base at the two concentrations; and 4) 1% silver
sulfadiazine (Sulfa) with Lanette cream base as the
positive control. Immediately after the injury, the treatments
were administered once per day for 14 days. After induction
of the lesion, the animals received 0.9% saline solution (sc)
for fluid replacement and were kept in a warm environment
under observation until complete recovery.
Burn wound contraction
The lesions were measured and photographed on
days 3, 5, 7, 9, 12, and 14 after induction of the superficial
burn. A digital caliper was used to measure the horizontal
(h) and vertical (v) size of the burn (mm), and then the
area of the lesion was calculated by multiplying the two
measurements, A = h  v (mm2). The rate of contraction
of the lesion was calculated by the formula: Contraction
(%) = (initial area – evaluation area) / (initial area)  100
(19). After examination of the macroscopic wound healing
(n=10/group), all mice were euthanized using an anes-
thetic overdose (xylazine and ketamine) and tissues were
collected immediately and kept at –80°C for biochemical
analyses.
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Tissue collection
The animals were euthanized with an overdose of
xylazine hydrochloride (30 mg/kg, ip) and ketamine
hydrochloride (300 mg/kg, ip) 3, 7, and 14 days after
treatment. Burn wounds from each animal were removed
as follows: half lesion on the 3rd day for determination of
myeloperoxidase activity and another half to analyze
mediators of inflammation; entire lesion on the 7th day for
histology and collagen fiber analyses; and entire lesion on
the 14th day for vascular endothelial growth factor (VEGF)
measurement. Samples for biochemical evaluation were
preserved in an ultra-freezer at –80°C and histological
samples were immediately processed.
Histological and collagen fibers analysis
The burn injuries were collected 7 days after injury
for histological analysis. Samples were removed and
fixed in 10% formol (pH 7.4) for 24 h (n=6/group).
Tissues were submitted to dehydration and embedded
in paraffin. Sections of those fragments were cut to 4-mm
thick slices and stained with hematoxylin and eosin.
Histopathological changes were evaluated by optical
microscopy (Olympus BX 51, Japan). The histopatho-
logical parameters were determined and scored from
0 to 4, where 0 corresponded to: absence of ulcer (AU),
remodeled connective tissue (RCT); score 1: AU,
fibrosis (F), slight chronic inflammation (CI); score 2:
presence of ulcer (PU), F, moderate CI; score 3: PU,
chronic inflammation process (granulation tissue); and
score 4: PU, acute process (dilated vessels, mixed
inflammatory infiltrate with neutrophils) (20). Staining
with picrosirius red (PSR) was performed to measure
the collagen fibers in the connective tissue of the burn
wounds. The Color Deconvolution (RGB) plugin of the
ImageJs software (NIH, USA) was used to measure the
percentage of collagen area represented by the red
image in relation to the total area of the image (21).
Myeloperoxidase activity assay
The myeloperoxidase (MPO) activity was deter-
mined in burn biopsies 3 days after burn injury (22).
The samples were homogenized using a Polytron
tissue extractor (Ultra Stirrer, Brazil) in phosphate buffer
pH 7.4, centrifuged at (13,953 g) for 30 min, and the pellet
obtained was used to determine myeloperoxidase activity
by oxidative reaction with 3,30,5,50-tetramethylbenzidine
(TMB; 1.6 mM, Sigmas) and oxygen peroxide (H2O2;
0.5 mM). The number of neutrophils was quantified from
a standard neutrophil curve (1105 neutrophils/well).
The absorbance of the samples (n=6/group) was quantified
in a Microplate Autoreader (Multiskan FC, Thermo Scien-
tific) at a wavelength of 450 nm and the results are reported
as the number of neutrophils/mg of tissue (cell/mg of
tissue).
Mediators of inflammation and vascular endothelial
growth factor measurement
The biopsies of the burns were performed 3 days after
injury to quantify the release of the inflammatory media-
tors tumor necrosis factor (TNF)-a, interleukin (IL)-1b, and
IL-10, and after 14 days to quantity the growth factor
VEGF (23). Tissues were triturated and homogenized at
10% (mg tissue/mL) at 4°C in PBS solution (pH 7.4), and
the residues were removed after centrifugation at 6,976 g
at 4°C for 5 min. The protocol was performed according to
the manufacturer’s recommendation for the conventional
sandwich technique (R&D Systemss, USA ). After the
ELISA protocol, the absorbance of the samples was
quantified with a spectrophotometer at wavelength of
450 nm. The results are reported as cytokines/mL of
homogenate and the concentration of the samples was
obtained from a serial dilution of recombinant cytokine
standard (n=6/group).
Statistical analysis
Data are reported as mean ± SE of each experi-
mental group. Statistical comparisons of the data were
performed by one-way ANOVA followed by the Tukey
post-test using GraphPad Prism version 5.0 (USA).
Differences between groups were considered significant
when Pp0.05.
Results
Identification of compounds in MFSOL of
S. obtusifolium leaves
Some of the major compounds were identified accord-
ing to their m/z and fragmentation profiles. Figure 1
shows the typical base peak intensity (BPI) chromatogram
Figure 1. Typical base peak intensity (BPI) chromatogram of
methanol fraction from leaf decoction of Sideroxylon obtusifolium
(MFSOL) in the negative ionization mode. ni: not identified; ud: up
to 1000 DA.
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of the methanol fraction from the leaf decoction. Also,
Table 1 shows the compounds with their retention times
(rt), m/z in negative ionization mode, molecular formula,
putative identification, and respective reference. 1H NMR
was used to detect the presence of NMP just for the water
fraction to yield 1.43 g of pure NMP (14.3%). This yield is
in agreement with a previous finding by qNMR (13). The
NMP spectrum extracted from the fraction corresponded
to the pure isolated compound N-methyl-(2S,4R)-trans-4-
hydroxy-L-proline (Supplementary Figures S1 and S2).
Table 1. Putative identification of the secondary metabolites present in the methanol fraction from leaf decoction of Sideroxylon
obtusifolium.
Peak Rt (min) Negative ionization mode Molecular formula Putative identification References
MS [M-H]- MS/MS ppm
1 0.89 317.0504 267.0718,
191.0534
–1.6 C12H14O10 ni –





–1.9 C30H26O12 Procyanidin –
3 3.06 289.0714 245.0822,
125.0243
0.7 C15H14O6 Catechin/epicatechin –




4.4 C45H38O18 Procyanidin C1/
Proanthocyanidin trimer
–

























–0.5 C45H38O13 ni –

















13 7.92 665.3960 325.1620,
116.9397
0.0 C29H62O16 ni –
Rt: retention time; ni: non-identified, ud: up to 1000 DA.
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MFSOL enhanced the viability of human keratinocyte
HaCaT cells
The proliferative assay revealed that MFSOL was not
cytotoxic to human keratinocytes at any of the incubation
periods. MFSOL was able to increase mitochondrial
viability (by the MTT assay) after 24, 48, and 72 h at
concentrations of 12.5–50 mg/mL (Po0.001). The con-
centration of 50 mg/mL of MFSOL stimulated increases in
cell viability of 42.8% (after 24 h), 47.5% (after 48 h), and
46.8% (after 72 h) compared to the Control group
(Po0.001) (Figure 2A, B, and C, respectively). At the
highest concentration (100 mg/mL), the increase was
43.6% (Po0.001) after 24 h. The SRB assay also
revealed an increase of viable cells, but less pronounced
than indicated by the MTT assay. After 24 and 48 h, the
concentration of 100 mg/mL of MFSOL increased the
viability of HaCaT cells by 14.5 and 21% (Po0.001),
which was also observed with 50 mg/mL (8.2 and
11.21%, respectively; Po0.001). These effects were
less pronounced after 72 h, when 25 and 50 mg/mL of
MFSOL caused viability increases of 7.1 and 7.4%
(Po0.001).
MFSOL stimulated proliferation and migration of
keratinocytes in the HaCaT scratch assay
To evaluate the effect of MFSOL on cell proliferation
and migration of HaCaT, the in vitro healing test known
as the scratch assay was used. Based on the results of
the MTT and SRB assays, we selected concentrations
of 25, 50, and 100 mg/mL to perform the scratch assay.
After 24 h, the percentages of open area observed
after treatment with 25 mg/mL (Po0.05) and 50 mg/mL
(Po0.001) of MFSOL were reduced by 14.5 and 34%,
respectively, compared to the Control (Figure 3A). This
effect was also observed 48 h after treatment with
12.5 mg/mL (22%; Po0.05), 25 mg/mL (28%; Po0.001),
and 50 mg/mL (38%; Po0.001) of MFSOL, respectively,
compared to the Control (Figure 3B). Finally, after 72 h,
the open area was reduced by treatment with 25 mg/mL
(42.1%; Po0.05) and 50 mg/mL (72.6%) of MFSOL
(Po0.001) compared to the Control (Figure 3C). The
effect of MFSOL on HaCaT was photographed and
visualized through rapid panotype staining. This was
observed by the higher cell density after treatment with
25 and 50 mg/mL of MFSOL compared with the Control
Figure 2. Effect of methanol fraction of Sideroxylon obtusifolium (MFSOL) on cell viability of human keratinocytes (HaCaT).
Increased viability of keratinocytes was produced by MFSOL (6.25–100 mg/mL) after 24 (A), 48 (B), and 72 (C) h of incubation by the
MTTassay and SRB assay (D, E, and F), respectively. To illustrate the HaCaT density, photographs were taken at 200 magnification
(scale bar 100 mm) 48 h after treatment with 25 and 50 mg/mL of MFSOL (G). Data are reported as means±SE of at least three
independent experiments. *Po0.05, **Po0.01, ***Po0.001, compared to the Control (Vehicle) group (one-way ANOVA followed by the
Tukey post-test).
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(Figure 3D). Considering the stimulatory effect of
MFSOL on cell proliferation and migration, we used
mitomycin C to inhibit cell duplication and thus enable
the isolated evaluation of the effect of MFSOL on cell
migration. At the concentration of 50 mg/mL, it was
efficient in stimulating the migration of the cells to the
center of the open area by 26% after 24 h (Po0.05) and
67% after 48 h (Po0.01) of incubation compared to the
Control (Figure 3E, F, and G).
CrMFSOL reduced the area of superficial burns
In the superficial burn model, the contraction of lesions
was measured for 14 days to monitor the evolution of the
area of superficial burns. The contraction rate of the Sham
and Vehicle groups was similar in all the periods studied
(Figure 4A-F). After 3 days, the treatment with 1.0%
CrMFSOL caused an increase of 123.2% (Po0.05) in the
contraction of lesions, while, the Sulfa group (Po0.05)
presented a similar effect (110.7%) compared to the
Vehicle group (Figure 4A). After 5 days (Figure 4B) and
7 days (Figure 4C), the groups receiving 0.5% CrMFSOL
(Po0.01; Po0.05), 1.0% CrMFSOL (Po0.05; Po0.01),
and Sulfa (Po0.01; Po0.01) showed increases of lesion
contraction, respectively, compared to the Vehicle group
(Figure 4C). After 9 days, only the group receiving 0.5%
CrMFSOL had greater (26%) lesion contraction (Po0.05)
compared to the Vehicle group (Figure 4D). Near the
closure of the lesion, after 12 and 14 days of analysis,
none of the groups presented differences (Figure 4E and
F). The photographs depict the evolution during the
healing process on the 3rd, 5th, 7th, 9th, 12th, and 14th
days (Figure 4G).
CrMFSOL promoted tissue remodeling improvement,
re-epithelialization, and collagen deposition of
superficial burns
Histopathological analysis of samples of superficial
burns in mice showed that after 7 days the Sham and
Vehicle groups had ulcers, granulation tissue, and the
presence of acute inflammatory infiltrate (Figure 5A and
B). On the other hand, in the Sulfa and the 0.5 and 1.0%
CrMFSOL groups (Po0.05), a thin epithelium covering
the ulcer was present, along with a corneal layer protect-
ing the newly formed epithelium. It was still possible to
Figure 3. Methanol fraction of Sideroxylon obtusifolium (MFSOL) stimulated cell proliferation and migration rates of HaCaT in the
scratch assay. A scratch was produced in a monolayer of HaCaTcells and photographs were taken, before (0 h) and 24 (A), 48 (B), and
72 h (C) after treatment with MFSOL (100 magnification; scale bar 200 mm) (D). Pretreatment with mitomycin C (10 mg/mL) was also
performed one hour before the introduction of the scratch to inhibit cell proliferation, allowing only evaluation of cell migration after 24 h
(E) and 48 h (F). The wells were photographed (100 , scale bar 200 mm) after 24 and 48 h (G). The data are reported as means±SE.
*Po0.05, **Po0.01, ***Po0.001 compared to the Control group (water) (one-way ANOVA followed by the Tukey test).
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Figure 4. Effect of methanol fraction of Sideroxylon obtusifolium (MFSOL) on the contraction of induced burns in mice. The percentage
of contraction of the burns was measured after 3, 5, 7, 9, 12, and 14 days (A, B, C, D, E, and F, respectively). The animals were treated
with a single daily application of dermatological creams (Cr) for 14 days. The CrMFSOL group received 0.5 and 1.0% MFSOL, the Sulfa
group received 1% silver sulfadiazine cream, and the Vehicle group was exposed to the base vehicle cream without any addition of
active substance. The superficial burns were photographed for macroscopic monitoring on days 3, 5, 7, 9, 12, and 14 after the burn was
produced (scale bar 10 mm) (G). One animal per group was chosen to represent the group according to the lesion contraction results.
The data are reported as mean±SE. *Po0.05, **Po0.01 compared to the Sham group; #Po0.05, ##Po0.01 compared to the Vehicle
group, (n=10 animals/group) (one-way ANOVA followed by the Tukey test).
Figure 5. Cream of methanol fraction of Sideroxylon obtusifolium (CrMFSOL) promoted improved tissue remodeling, reepithelialization,
and stimulated collagen production on superficial burns 7 days after treatment. Photomicrographs of histological slides (hematoxylin-
eosin staining) of burn lesions on the 7th day after injury for the groups Sham (A), Vehicle (B), silver sulfadiazine (C), 0.5% CrMFSOL
(D), and 1.0% CrMFSOL (E) (n=6 animals/group). Black arrows indicate the presence of acute inflammatory infiltrate in groups A and B,
while red arrows indicate the presence of atrophic epithelium, presence of a corneal layer, and absence of ulcer in groups C, D, and E.
The lesions were stained with picrosirius red and photographed in six fields (200, scale bar 200 mm). The percentage of total
collagen present on the 7th day was determined by the ImageJs software (F). The data are reported as mean±SE of the six areas of
each wound per group. *Po0.05 compared to the Sham group; #Po0.05 compared to the Vehicle group (n=6 animals/group per day)
(one-way ANOVA followed by the Tukey test).
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observe the transition from acute to chronic inflam-
matory infiltrate and the remodeling of connective tissue
(Figure 5C, D, and E, respectively). To determine the total
collagen deposition in the tissue, picrosirius red staining
was used 7 after days of treatment. The Vehicle and Sham
groups had similar percentages of total collagen. The
corresponding percentages of collagen production in the
Sulfa and the 0.5 and 1.0% CrMFSOL groups were 36,
30.7, and 48.1% (Po0.05), respectively compared with
the Vehicle group (Figure 5F).
Effect of CrMFSOL on cytokine inflammatory status of
superficial burns
Treatment with 0.5% CrMFSOL reduced (Po0.05)
the activity of MPO by 32% compared to the Vehicle
group 3 days after burn injury (Figure 6A). Moreover,
the levels of TNF-a were not altered by 0.5 or 1.0%
CrMFSOL (Figure 6B). However, CrMFSOL at 0.5%
(Po0.001) and 1.0% (Po0.01) increased IL-1b release
by 112.5 and 94.4%, respectively, compared to the
Vehicle group, as did treatment with Sulfa (Po0.001)
(Figure 6C). Additionally, the release of IL-10, an anti-
inflammatory cytokine, was higher in all treated groups
compared with the Vehicle group. Treatment with 0.5%
CrMFSOL caused increases of 153.7% (Po0.001) and
59.8% (Po0.01) compared to the Vehicle and Sulfa
groups, respectively (Figure 6D).
CrMFSOL stimulated release of VEGF in superficial
burns
To evaluate the angiogenesis process, the VEGF level
was measured 14 days after induced superficial burn injury.
The treatment with 0.5% CrMFSOL increased VEGF
release by 95.6% (Po0.05) compared to the Vehicle
group (Figure 6E).
Discussion
The present work reports, for the first time, the healing
activity on burn wounds of a methanol fraction from
Sideroxylon obtusifolium leaves (MFSOL). S. obtusifolium
is one of the most important native species of the
Caatinga biome targeted for conservation and sustainable
maintenance. The plant has been mentioned by local
experts as among the five most important native species
with respect to therapeutic value, being used to treat pain
and injuries from blows. However, the use of medicinal
plants in the Caatinga biome often involves the removal of
the bark, a practice that can kill the plant (24). In contrast
to the traditional use of stem bark, this work improves the
chances of conservation by demonstrating the medicinal
properties of the leaves as well.
Besides the interest in bioactive compounds, this
plant’s fruit also has a high nutritional potential (25).
A previously published detailed metabolic profile of the
ethanol extract of S. obtusifolium leaves revealed sapo-
nins and flavonoids as the main constituents. The authors
also identified a new glycoside triterpene and flavonol
glycosides (quercetin-glycoside, kaempferol-glycoside),
which were also identified in MFSOL (6). In addition,
catechin/epicatechin, procyanidin C1, and proanthocyani-
din were identified in MFSOL. The use of natural products
with anti-inflammatory, antioxidant, antibacterial, and pro-
collagen synthesis properties can aid in wound healing.
Bioactive constituents of the chemical classes of alka-
loids, flavonoids, tannins, terpenoids, saponins, and
phenolic compounds have been found to have healing
benefits. These substances are generally absorbed well
by the skin and modulate different stages of healing (26).
Fujishima et al. identified 13 compounds in a hydroetha-
nolic extract from the leaves of C. americana, mainly
Figure 6. The treatment with methanol fraction of Sideroxylon obtusifolium cream (CrMFSOL) reduced myeloperoxidase activity (MPO)
and stimulated release of interleukin (IL)-1b and IL-10 after 3 days, and vascular endothelial growth factor (VEGF) after 14 days. The
levels of tumor necrosis factor (TNF)-a were not reduced significantly. The data are reported as mean±SE. #Po0.05, ##Po0.01,
###Po0.001 compared to the Vehicle group; aPo0.05 and aaaPo0.001 compared to the Sulfa group n=6 animals/group per day)
(one-way ANOVA followed by the Tukey test).
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quercetin, kaempferol, glucoside derivatives, catechin,
and epicatechin, which could explain the excellent healing
effect (27).
MFSOL was not cytotoxic and promoted increased
viability of human keratinocytes (HaCaT), suggesting an
effect on the proliferation of HaCaT. In the scratch assay,
MFSOL showed a proliferative and migratory effect on
keratinocytes during wound healing. To evaluate only cell
migration, mitomycin C, an antimitotic agent, was used to
interfere with cell duplication in the scratch assay. MFSOL
(25 and 50 mg/mL) stimulated not only proliferation but
also the migration of HaCaT. Epidermal cell turnover is
fundamental for rapid wound healing, in which keratino-
cytes are stimulated to proliferate by regulating growth
factors and intercellular contact (28).
As a pharmacological model, the induction of super-
ficial burns in mice was chosen to evaluate the effect of a
topical cream (CrMFSOL) containing MFSOL at concen-
trations of 0.5 and 1.0% for 14 days. These concentrations
of MFSOL corresponded to the best concentrations tested
in vitro (50 and 100 mg/mL) in keratinocytes. The faster
evolution of the contraction area of burn wounds, caused
by treatment with CrMFSOL after 3, 5, 7, and 9 days,
reduced the risk of infections and accelerated the other
stages of healing, such as proliferation and remodeling. Its
effect was similar to that observed in the Control group
(silver sulfadiazine), which received the standard treat-
ment for the prevention of infections and the promotion of
burn healing (29).
Collagen is a structural protein responsible for tissue
repair and wound healing. Proline and its metabolite
(hydroxyproline) are unique amino acids and constitute
one-third of amino acids present in collagen proteins.
Proline also protects tissues from free radicals and
reactive oxygen species (ROS), which induce tissue
damage due to their antioxidant potential (30). Proline is
only considered essential for the body in situations of
burns and other injuries. It plays a crucial role in collagen
synthesis and wound healing, mainly by regulating cell
differentiation, cell nutrition, growth signaling factors,
protein synthesis, and excretion of oxidants from the body
(31). The high demand for proline during wound repair can
cause a local proline deficiency. It has been suggested
that the increase in proline bioavailability would be an
interesting strategy to optimize collagen biosynthesis (32).
According to Thangavel et al. (30), the topical treatment
with CrMFSOL stimulated the early formation of new
epithelium and remodeling of connective tissue, with a
higher collagen deposition after 7 days. The incorporation
of L-proline in a hydrogel accelerated wound healing by
enhanced wound tissue regeneration and repair.
The progression of thermal injury damages adjacent
capillaries, causing ischemia, which activates adhesion
of polymorphonuclear cells such as neutrophils, which
release inflammatory mediators and promote the produc-
tion of ROS (33). While TNF-a release induces the
fundamental inflammatory response in damaged tissue,
the high level of IL-1b in mouse burns was correlated with
the increased activity of epidermal keratinocytes. These
cells work to restore the epidermal barrier function when
stimulated by nanofibers of peptide hydrogels (34). The
topical application of quercetin on full-thick epidermal burn
wounds in rats produced a healing effect. It has been
suggested that quercetin inhibits free radical damage of
fibroblasts and keratinocytes, and this reduces inflam-
mation and histamine release in burned skin and the
surrounding tissue (35). Treatment with 0.5% CrMFSOL
caused an increase in IL-1b levels, but it did not influence
TNF-a release in burn injuries. Moreover, 0.5% CrMFSOL
reduced MPO activity 3 days after treatment, which may
have influenced the transition from acute to chronic
inflammatory infiltrate after 7 days, earlier than the
treatment with silver sulfadiazine. The ethanol extract of
the inner bark of quixaba shows antinociceptive, analge-
sic, and anti-inflammatory effects, blocking leukocyte
migration and establishing antioxidant activity, attributed
to flavonoids (36). A polyphenol-enriched fraction from
Annona crassiflora fruit peel containing epi-catechin,
procyanidins B2 and C1, quercetin-glucoside, and kaemp-
ferol shows anti-inflammatory properties by reducing the
activity of neutrophils and macrophages in cutaneous
wounds. These compounds also favored the synthesis of
collagen and the closure of wounds (37).
As an anti-inflammatory factor, IL-10 is also produced
by epidermal keratinocytes and is important in the
suppression of ROS and nitric oxide (NO) and the control
of proinflammatory cytokines secreted by macrophages
(38). Briefly, 0.5% CrMFSOL caused an increase in IL-10
level, while MFSOL was able to modulate the inflamma-
tory response and contribute to healing of burned tissue.
Furthermore, IL-1b has been reported to stimulate VEGF
expression during inflammation, which consequently
stimulates migration and proliferation of endothelial cells
by the promotion of angiogenesis (39). One study reported
that 0.3% quercetin treatment of wounds accelerates
healing by a variety of biological effects: rapid wound
contraction, modulation of inflammatory and anti-inflam-
matory cytokines, increased VEGF and TGF-b1, increased
antioxidant status, and enhanced fibroblast proliferation,
with better collagen deposition (40). Similarly, 0.5%
CrMFSOL promoted a greater release of VEGF 14 days
after treatment of burn injuries, which may have con-
tributed to better epithelization and reorganization of the
connective tissue.
Conclusions
The methanol fraction extracted from the leaf decoc-
tion of Sideroxylon obtusifolium (MFSOL) demonstrated
wound healing potential by stimulating proliferation and
migration of human keratinocytes. Also, MFSOL modulated
the inflammatory response and improved tissue repair of
superficial burns in mice. Thus, the anti-inflammatory and
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wound healing potential of MFSOL provided support for
further studies to enable the development of an herbal
product for the treatment of burns and other wounds.
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